53 related articles for article (PubMed ID: 25461314)
1. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
3. A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK.
Ma Y; Cui Q; Zhu W; Wang M; Zhai L; Hu W; Liu D; Liu M; Li Y; Li M; Han W
Drug Des Devel Ther; 2024; 18():1531-1546. PubMed ID: 38737331
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer.
Kumar P; Singh R; Sharma D; Hassan QP; Gopu B; Anal JMH
Bioorg Med Chem Lett; 2024 Jul; 107():129795. PubMed ID: 38750906
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a new dihydroeugenol-chalcone hybrid with cytotoxic and anti-migratory potential: A dual-action hit for cancer therapeutics.
Nakao IA; Almeida TC; Cardoso Reis AC; Coutinho GG; Hermenegildo AM; Cordeiro CF; da Silva GN; Dias DF; Brandão GC; Pinto Braga SF; de Souza TB
Bioorg Med Chem; 2023 Dec; 96():117516. PubMed ID: 37944413
[TBL] [Abstract][Full Text] [Related]
7. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications.
Wang H; Zhu J; Zhang Q; Tang J; Huang X
Arch Pharm (Weinheim); 2024 May; 357(5):e2300640. PubMed ID: 38227398
[TBL] [Abstract][Full Text] [Related]
8. Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer.
Chen S; Li M; Xue C; Zhou X; Wei J; Zheng L; Duan Y; Deng H; Tang F; Xiong W; Xiang B; Zhou M
Drug Des Devel Ther; 2024; 18():1321-1338. PubMed ID: 38681206
[TBL] [Abstract][Full Text] [Related]
9. Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents.
Montero V; Montana M; Carré M; Vanelle P
Eur J Med Chem; 2024 May; 271():116360. PubMed ID: 38614060
[TBL] [Abstract][Full Text] [Related]
10. Flexibility in the bridge of chalcone derivatives is important for the inhibition of cellular growth.
Stantliff TM; Hill A; Kuo ME; Neal HE; Harrod TC; Goens K; Mashuta M; Christianson AM; Krzysiak AJ
Bioorg Med Chem Lett; 2023 Oct; 95():129467. PubMed ID: 37666364
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds.
Nian C; Gan X; Liu Q; Wu Y; Kong M; Zhang P; Jin M; Dong Z; Li W; Wang L; He W; Li X; Wu J
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38847254
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiproliferative activity, and in silico insights of new 3-benzoylamino-benzo[b]thiophene derivatives.
Martorana A; Gentile C; Perricone U; Piccionello AP; Bartolotta R; Terenzi A; Pace A; Mingoia F; Almerico AM; Lauria A
Eur J Med Chem; 2015 Jan; 90():537-46. PubMed ID: 25486425
[TBL] [Abstract][Full Text] [Related]
13. Antimitotic activity of structurally simplified biaryl analogs of the anticancer agents colchicine and combretastatin A4.
McNulty J; van den Berg S; Ma D; Tarade D; Joshi S; Church J
Bioorg Med Chem Lett; 2015 Jan; 25(1):117-21. PubMed ID: 25466200
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new indole-based chalcones as potential antiinflammatory agents.
Özdemir A; Altintop MD; Turan-Zitouni G; Çiftçi GA; Ertorun İ; Alataş Ö; Kaplancikli ZA
Eur J Med Chem; 2015 Jan; 89():304-9. PubMed ID: 25462246
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
[TBL] [Abstract][Full Text] [Related]
16. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
17. [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice.
WalyEldeen AA; El-Shorbagy HM; Hassaneen HM; Abdelhamid IA; Sabet S; Ibrahim SA
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1225-1238. PubMed ID: 35881165
[TBL] [Abstract][Full Text] [Related]
18. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.
Miles X; Vandevoorde C; Hunter A; Bolcaen J
Front Oncol; 2021; 11():703442. PubMed ID: 34307171
[TBL] [Abstract][Full Text] [Related]
19. Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness.
Moreira J; Almeida J; Saraiva L; Cidade H; Pinto M
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205272
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-coding LINC00657 regulates tumorigenesis of glioblastoma by acting as a molecular sponge of miR-190a-3p.
Chu L; Yu L; Liu J; Song S; Yang H; Han F; Liu F; Hu Y
Aging (Albany NY); 2019 Mar; 11(5):1456-1470. PubMed ID: 30837348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
